Health Information Search Results
Peer Reviewed Scientific Research Reports.
|<< Prev 20 ||Showing 1 to 5 of 5 Matches||Next 20 >>|
1. Women-only and mixed-gender drug abuse treatment programs: Service needs, utilization and outcomes.
Match Strength: 7.624
OBJECTIVES: This prospective longitudinal study examined service needs, utilization and outcomes for 189 women in women-only (WO) programs and 871 women in mixed-gender (MG) programs. METHODS: The Addiction Severity Index was administered at both intake and the 9-month follow-up interview to assess clients' problem severity and outcomes, and the Treatment Service Review was given at the 3-month interview to measure service utilization. Treatment completion and arrests were based on official records. RESULTS: Compared to women in MG programs, women in WO programs were more likely to be White, ... Read More »
» Published in Drug Alcohol Depend. 2006 Sep 20;
2. Economic manifestations of opiate addiction: Evidence from historical data from colonial Indonesia.
Match Strength: 5.538
The aim of this paper is to demonstrate, using an example, the utility of historical data to illuminate important questions in the field of drug dependence research. The literature on the consumption of addictive substances often characterizes users as being one of two types: "addicts" and "casual users." An econometric characterization of the responses of opium consumers in the late-colonial Netherlands Indies to changes in the price of opium and other important variables is provided, which explicitly acknowledges the existence of different types of opium smokers, as modeled in the underlying ... Read More »
» Published in Drug Alcohol Depend. 2006 Sep 16;
3. The science of stimulant abuse.
Match Strength: 5.516
Stimulant medications, although classified by the US Drug Enforcement Agency as controlled with a Schedule IIa rating, are ubiquitous in our society because of their popularity as an effective treatment for childhood ADHD. The number of stimulant products available for practitioners has tripled in the last decade. Although stimulants' action on central dopamine systems can be reinforcing, especially when delivered via intraperitoneal or intravenous routes in laboratory animals, they are far less addicting when taken orally by children in the context of a medical treatment. Fortunately, the ... Read More »
» Published in Pediatr Ann. 2006 Aug;35(8):552-6.
4. Eating, sleeping and rewarding: orexin receptors and their antagonists.
Match Strength: 5.484
The orexin system plays a key role in the control of eating, sleeping and rewarding. This review summarizes the latest developments in the identification of orexin receptor antagonists. By using a selective orexin-1 receptor antagonist, SB-334867-A (GlaxoSnzithKline plc), the in vivo futctions of both the orexin-1 and orexin-2 receptors have been elucidated. This review also sunmmarizes the literature and current opinions up to May 2006 on the therapeutic utility of orexin receptor antagonists for the treatment of eating disorders, sleeping disorders and drug addiction. Publication Types: ... Read More »
» Published in Curr Opin Drug Discov Devel. 2006 Sep;9(5):551-9.
5. Regardless of psychiatric severity the addition of contingency management to standard treatment improves retention and drug use outcomes.
Match Strength: 4.368
The relationship between psychiatric severity and substance use disorders treatment outcome was assessed in 393 individuals who received either standard treatment or standard treatment plus contingency management. The sample was divided into groups of low, moderate, and high psychiatric severity based upon baseline Addiction Severity Index psychiatric composite scores. Participants in the high psychiatric severity group reported a greater prevalence of psychiatric hospitalization, psychiatric medications, and suicide attempts, as well as poorer baseline psychosocial functioning. In terms of ... Read More »
» Published in Drug Alcohol Depend. 2006 Sep 25;
|<< Prev 20 ||Showing results 1 to 5 of 5||Next 20 >>|
* All information on Level1Diet.com is for educational purposes only. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Before changing your diet, or adding supplements to your diet, or beginning an exercise program, everyone should consult a qualified and licensed health practitioner; a physician, dietician or similar professional.